Geode Capital Management
BNGO icon

Geode Capital Management’s Bionano Genomics BNGO Stock Holding History

Geode Capital Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$121K Sell
77,274
-12,719
-14% -$16.1K ﹤0.01% 4012
2026
Q2 		$102K Sell
89,993
-77,540
-46% -$93.4K ﹤0.01% 4097
2026
Q1 		$196K Buy
167,533
+100,767
+151% +$129K ﹤0.01% 3925
2025
Q4 		$102K Buy
66,766
+39,928
+149% +$69.1K ﹤0.01% 4092
2025
Q3 		$45.9K Buy
26,838
+7,967
+42% +$25.3K ﹤0.01% 4310
2025
Q2 		$61.9K Buy
18,871
+3,365
+22% +$12.6K ﹤0.01% 4169
2025
Q1 		$43.3K Sell
15,506
-1,122
-7% -$7.34K ﹤0.01% 4225
2024
Q4 		$288K Buy
16,628
+1,914
+13% +$32.7K ﹤0.01% 3781
2024
Q3 		$401K Buy
14,714
+4,727
+47% +$147K ﹤0.01% 3681
2024
Q2 		$406K Buy
9,987
+3,297
+49% +$181K ﹤0.01% 3647
2024
Q1 		$446K Buy
6,690
+410
+7% +$30.6K ﹤0.01% 3660
2023
Q4 		$712K Buy
6,280
+580
+10% +$60.6K ﹤0.01% 3476
2023
Q3 		$1.04M Buy
5,700
+718
+14% +$188K ﹤0.01% 3303
2023
Q2 		$1.82M Sell
4,982
-4,675
-48% -$2.11M ﹤0.01% 3141
2023
Q1 		$6.43M Buy
9,657
+405
+4% +$360K ﹤0.01% 2519
2022
Q4 		$8.1M Buy
9,252
+484
+6% +$609K ﹤0.01% 2398
2022
Q3 		$9.6M Buy
8,768
+181
+2% +$239K ﹤0.01% 2292
2022
Q2 		$7.11M Buy
8,587
+1,266
+17% +$1.3M ﹤0.01% 2483
2022
Q1 		$11.3M Sell
7,321
-537
-7% -$725K ﹤0.01% 2268
2021
Q4 		$14.1M Buy
7,858
+71
+0.9% +$190K ﹤0.01% 2208
2021
Q3 		$25.7M Sell
7,787
-32
-0.4% -$112K ﹤0.01% 1780
2021
Q2 		$34.4M Buy
7,819
+5,026
+180% +$19.8M ﹤0.01% 1614
2021
Q1 		$13.5M Buy
2,793
+1,219
+77% +$6.87M ﹤0.01% 2142
2020
Q4 		$2.91M Buy
1,574
+547
+53% +$204K ﹤0.01% 2881
2020
Q3 		$400K Buy
1,027
+492
+92% +$191K ﹤0.01% 3490
2020
Q2 		$163K Buy
535
+123
+30% +$30.9K ﹤0.01% 3714
2020
Q1 		$112K Sell
412
-9
-2% -$5.08K ﹤0.01% 3728
2019
Q4 		$313K Buy
+421
New +$246K ﹤0.01% 3658

Other funds holding BNGO

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Carret Asset Management
Carret Asset Management New York $1.14B AUM 25.06% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Geode Capital Management's BNGO Position: Q3 2026 in Review

Geode Capital Management reduced its Bionano Genomics (BNGO) stake by 14% in Q3 2026, selling an estimated $16.1K and leaving 77,274 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #4012.

Geode Capital Management first reported a position in BNGO in Q4 2019 and has held it in 28 quarters since. The position peaked at $34.4M in Q2 2021. 9 funds tracked by Wall St. Rank hold BNGO as of Q3 2026.

  • Geode Capital Management held 77,274 shares of Bionano Genomics worth $121K as of Q3 2026.
  • Geode Capital Management sold 12,719 Bionano Genomics shares in Q3 2026, an estimated $16.1K.
  • Bionano Genomics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4012 holding.
  • Geode Capital Management first reported a position in Bionano Genomics in Q4 2019 and has held it in 28 quarters since.
  • Geode Capital Management's Bionano Genomics position peaked at $34.4M in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.